Last reviewed · How we verify

NCT01017094

Can Silversulfadiazine Prevent Pin-site Infection in Open Tibial Fracture?: A Randomized Controlled Trial

Completed Phase 3 Last updated 19 November 2009
What this trial tests

Phase 3 trial testing silversulfadiazine in Tibial Fracture in 30 participants. Completed in 1 November 2009.

Timeline
1 September 2007
Primary endpoint
1 June 2008
1 November 2009

Quick facts

Lead sponsorPrince of Songkla University
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 September 2007
Primary completion1 June 2008
Estimated completion1 November 2009
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Prince of Songkla University

Who can join

Adults 15 to 60, any sex, with Tibial Fracture. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

This study aimed to compare the efficacy of pin-tract infection prevention between silversulfadiazine and dry dressing. Methods: 30 patients with an open tibial fracture admitted to Songklanagarind hospital from September 2007 to June 2008 and treated by emergency debridement and external fixation were randomized into two groups, one treated with silversulfadiazine for infection prophylaxis (15) and a control group treated with dry dressing only (15). All patients were followed until the external fixator was removed. Pin-site infections were assessed and graded at each follow-up visit by an orthopaedist blinded to the mode of treatment. A culture from the pin site was done if an infection occurred.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tibial Fracture

Currently open trials in the same condition.

Other Prince of Songkla University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01017094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing